Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Experimental Oncology is Scopus-indexed (Q3, CiteScore 1.4). Published by Morion LLC.
Checked against the index lists dated .
ISSN 1812-9269Verify ISSN ↗
Publisher: Morion LLC
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 315 / 428 | 26th | Q3 |
| Cancer Research | 199 / 233 | 14th | Q4 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1984–present, best quartile Q3, CiteScore 1.4.
Experimental Oncology is Q3 in Oncology (rank 315 of 428) and Q4 in Cancer Research (rank 199 of 233), by CiteScore 2025.
Experimental Oncology is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 1.4, quartile Q3, 26th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.261, quartile Q4, with an H-index of 52.
Experimental Oncology is published by Morion LLC. Its ISSN is 1812-9269.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Experimental Oncology has an h-index of 23 and a 2-year mean of 1.15 citations per paper (OpenAlex). Its Scopus CiteScore is 1.4, quartile Q3. On 2-year citations it ranks #276 of 424 Scopus journals in Oncology.
Experimental Oncology published 69 papers in 2025; its busiest recent year was 2023 with 105. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2024–2026), authors are most often from Ukraine (78.8%), Türkiye (4%) and Iraq (3%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.